http://www.neomatrix.com - Early detection is key in fighting breast cancer. The new HALO exam uses a device that aspirates fluid from the nipple. The adjustable cups are fitted to a woman's breasts. The system applies warmth, suction and massage, bringing fluid to the surface of the nipple. A normal result is either no fluid aspirated or the fluid is without atypical cells. If cells are atypical, there is a 4 to 5 times increased chance of developing breast cancer. HALO is not designed to diagnose. It is a risk assessment tool. Halo can help women to assess their breast cancer risk level early. Learn more at http://www.neomatrix.com
